This fall, The FDA recommended that Teva Neuroscience’s drug rasagiline, brand name Azilect, should not be granted status “to slow the clinical progression of PD.”
Mentioned in this episode:
From now through December 2, you can help accelerate Parkinson’s research. This Giving Tuesday, all donations to The Michael J. Fox Foundation will be matched up to $4 million, which means your impact will be doubled. Visit michaeljfox.org/givetoresearch to be part of the cure.
